336-77-6

Basic information

• Product Name: (11beta)-9-fluoro-11-hydroxy-17,21-epoxypregn-4-ene-3,20-dione
• Synonyms: 17,21-Epoxy-9-fluoro-11beta-hydroxypregn-4-ene-3,20-dione; 17,21-Epoxy-9-fluoro-11beta-hydroxyprogesterone
• CAS NO: 336-77-6
• Molecular Formula: C₂₁H₂₇FO₄
• Molecular Weight: 362.4351
• Mol File: 336-77-6.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 532.8°C at 760 mmHg
• Flash Point: 276°C
• Density: 1.3g/cm³
• Vapor Pressure: 1.42E-13mmHg at 25°C
• Refractive Index: 1.576
• CAS DataBase Reference: (11beta)-9-fluoro-11-hydroxy-17,21-epoxypregn-4-ene-3,20-dione(CAS DataBase Reference)
• NIST Chemistry Reference: (11beta)-9-fluoro-11-hydroxy-17,21-epoxypregn-4-ene-3,20-dione(336-77-6)
• EPA Substance Registry System: (11beta)-9-fluoro-11-hydroxy-17,21-epoxypregn-4-ene-3,20-dione(336-77-6)

Safety Data

• Hazardous Substances Data: 336-77-6(Hazardous Substances Data)

Usage

Description

(11beta)-9-fluoro-11-hydroxy-17,21-epoxypregn-4-ene-3,20-dione is a synthetic corticosteroid characterized by its potent anti-inflammatory and immunosuppressive properties. (11beta)-9-fluoro-11-hydroxy-17,21-epoxypregn-4-ene-3,20-dione is designed to exert a significant impact on the body's immune response and inflammation levels, making it a valuable asset in the treatment of various conditions.
Used in Pharmaceutical Industry:
(11beta)-9-fluoro-11-hydroxy-17,21-epoxypregn-4-ene-3,20-dione is used as an anti-inflammatory and immunosuppressive agent for the treatment of various inflammatory and autoimmune conditions. Its application is primarily due to its ability to bind to glucocorticoid receptors, thereby suppressing the immune response and reducing inflammation. This makes it effective in managing conditions such as rheumatoid arthritis, asthma, and allergic reactions.
Used in Metabolic Regulation:
This corticosteroid also plays a role in the metabolism of carbohydrates, fats, and proteins in the body. Its influence on these metabolic pathways can contribute to the overall management of certain health conditions, although it is important to monitor and manage potential side effects that may arise from its use.
Despite its therapeutic benefits, the use of (11beta)-9-fluoro-11-hydroxy-17,21-epoxypregn-4-ene-3,20-dione must be approached with caution due to the potential for side effects such as increased risk of infection, hypertension, and osteoporosis. As such, it should be administered under the guidance and supervision of a qualified healthcare professional to ensure safe and effective treatment.

Upstream product

• 382-65-0 21-O-methylsulfonyl-9a-fluorocortisone